The role of YWHAZ in cancer: A maze of opportunities and challenges

被引:78
作者
Gan, Yun [1 ]
Yee, Feng [2 ]
He, Xing-Xing [1 ]
机构
[1] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Inst Liver & Gastrointestinal Dis, Wuhan, Peoples R China
[2] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Pediat, Wuhan, Peoples R China
基金
中国国家自然科学基金;
关键词
YWHAZ; cancer; function; molecular mechanism; biomarker; EPITHELIAL-MESENCHYMAL TRANSITION; ISOFORM-SPECIFIC EXPRESSION; BREAST-CANCER; LUNG-CANCER; UP-REGULATION; HEPATOCELLULAR-CARCINOMA; CELL-PROLIFERATION; GENE-EXPRESSION; PROGNOSTIC-SIGNIFICANCE; 14-3-3-ZETA EXPRESSION;
D O I
10.7150/jca.41316
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
YWHAZ (also named 14-3-3 zeta) is a central hub protein for many signal transduction pathways and plays a significant role in tumor progression. Accumulating evidences have demonstrated that YWHAZ is frequently up-regulated in multiple types of cancers and acts as an oncogene in a wide range of cell activities including cell growth, cell cycle, apoptosis, migration, and invasion. Moreover, YWHAZ was reported to be regulated by microRNAs (miRNAs) or long non-coding RNAs and exerted its malignant functions by targeting downstream molecules like protein kinase, apoptosis proteins, and metastasis-related molecules. Additionally, YWHAZ may be a potential biomarker of diagnosis, prognosis and chemoresistance in several cancers. Targeting YWHAZ by siRNA, shRNA or miRNA was reported to have great help in suppressing malignant properties of cancer cells. In this review, we perform literature and bioinformatics analysis to reveal the oncogenic role and molecular mechanism of YWHAZ in cancer, and discuss the potential clinical applications of YWHAZ concerning diagnosis, prognosis, and therapy in malignant tumors.
引用
收藏
页码:2252 / 2264
页数:13
相关论文
共 50 条
[31]   Involvement of miR-451 in resistance to paclitaxel by regulating YWHAZ in breast cancer [J].
Wang, Wenrui ;
Zhang, Lingyu ;
Wang, Yangyang ;
Ding, Yongxing ;
Chen, Tiantian ;
Wang, Yueyue ;
Wang, Haifeng ;
Li, Yu ;
Duan, Kecai ;
Chen, Sulian ;
Yang, Qingling ;
Chen, Changjie .
CELL DEATH & DISEASE, 2017, 8 :e3071-e3071
[32]   How do changes in the mtDNA and mitochondrial dysfunction influence cancer and cancer therapy? Challenges, opportunities and models [J].
van Gisbergen, M. W. ;
Voets, A. M. ;
Starmans, M. H. W. ;
de Coo, I. F. M. ;
Yadak, R. ;
Hoffmann, R. F. ;
Boutros, P. C. ;
Smeets, H. J. M. ;
Dubois, L. ;
Lambin, P. .
MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH, 2015, 764 :16-30
[33]   The Role of miR-129-5p in Cancer: A Novel Therapeutic Target [J].
Xu, Shan ;
Li, Wei ;
Wu, Jing ;
Lu, Yuru ;
Xie, Ming ;
Li, Yanlan ;
Zou, Juan ;
Zeng, Tiebing ;
Ling, Hui .
CURRENT MOLECULAR PHARMACOLOGY, 2022, 15 (04) :647-657
[34]   CRISPR Technology in Cancer Diagnosis and Treatment: Opportunities and Challenges [J].
Shademan, Behrouz ;
Masjedi, Sepideh ;
Karamad, Vahidreza ;
Isazadeh, Alireza ;
Sogutlu, Fatma ;
Rad, Mohammad Hosein Saeedi ;
Nourazarian, Alireza .
BIOCHEMICAL GENETICS, 2022, 60 (05) :1446-1470
[35]   Extracellular vesicles as circulating cancer biomarkers: opportunities and challenges [J].
Lane, R. E. ;
Korbie, D. ;
Hill, M. M. ;
Trau, M. .
CLINICAL AND TRANSLATIONAL MEDICINE, 2018, 7
[36]   Integrative medicine in the era of cancer immunotherapy: Challenges and opportunities [J].
Zhang, Ning ;
Xiao, Xiao-he .
JOURNAL OF INTEGRATIVE MEDICINE-JIM, 2021, 19 (04) :291-294
[37]   Research in Perioperative Care of the Cancer Patient: Opportunities and Challenges [J].
Cata, Juan P. .
CURRENT ONCOLOGY, 2023, 30 (01) :1186-1195
[38]   Advanced nanomedicine and cancer: Challenges and opportunities in clinical translation [J].
Gonzalez-Valdivieso, Juan ;
Girotti, Alessandra ;
Schneider, Jose ;
Javier Arias, Francisco .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2021, 599
[39]   RNA interference therapeutics for cancer: Challenges and opportunities (Review) [J].
Bora, Roop Singh ;
Gupta, Dikshi ;
Mukkur, Trilochan Kanwaljit Singh ;
Saini, Kulvinder Singh .
MOLECULAR MEDICINE REPORTS, 2012, 6 (01) :9-15
[40]   Evolution of targeted therapies in cancer: opportunities and challenges in the clinic [J].
Santhosh, Sam ;
Kumar, Prasanna ;
Ramprasad, Vedam ;
Chaudhuri, Amitabha .
FUTURE ONCOLOGY, 2015, 11 (02) :279-293